BioNTech

Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine approved by US FDA PMLiVE11:15Pfizer FDA Covid

FDA approves updated COVID vaccines for 2026-27 season Just The News16:12FDA Covid Pfizer Vaccine

FDA approves updated COVID vaccines NewsMax13:10FDA Covid Pfizer Vaccine

FDA approves latest version of Pfizer's COVID-19 mRNA vaccine UPI00:30Pfizer FDA Covid

FDA approves updated COVID vaccines targeting XFG ‘Stratus’ variant FOX13 Seattle22:24FDA Pfizer Moderna

BioNTech stock dips after BNT122-01 trial termination Benzinga16:19Stock Markets (World) Stock Market (US) Stock Market

BioNTech vs. Moderna: Which is the better cancer vaccine stock to buy now? The Motley Fool22:40Moderna mRNA Coronavirus Vaccine

BioNTech halted a cancer vaccine trial, and Genentech says there were more deaths in the vaccine group Medical Daily02:00Genentech mRNA Pfizer Vaccine

Why is BioNTech stock gaining Monday? Benzinga15:41Stock Markets (World) Stock Market Pharma

Is BioNTech stock a no-brainer buy on the dip? The Motley Fool20:32Stock Markets (World) Stock Market (US) Stock Market

Latest News

Yesterday

Why Is BioNTech Stock Gaining Monday? Benzinga15:41 14-Sept-26

BioNTech's Gotistobart Nearly Doubles Median Overall Survival In Previously Treated Squamous Nsclc RTT News12:38 14-Sept-26

In the last 7 days

Protecting Intellectual Property Rights Will Save Lives Now and in the Future The Independent Institute (Weblog)08:31 9-Sept-26

How Trial Termination At BioNTech (BNTX) Has Changed Its Investment Story Simply Wall St21:26 8-Sept-26

In the last month

Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine approved by US FDA PMLiVE11:15 4-Sept-26

BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now? The Motley Fool22:40 3-Sept-26

Is BioNTech Stock a No-Brainer Buy on the Dip? The Motley Fool20:32 2-Sept-26

BioNTech (BNTX) Halts Cancer Trial, Is The 15% Undervaluation Still Credible? Simply Wall St13:20 2-Sept-26

BioNTech Halted a Cancer Vaccine Trial, and Genentech Says There Were More Deaths in the Vaccine Group Medical Daily02:00 1-Sept-26

FDA approves updated COVID vaccines targeting XFG ‘Stratus’ variant FOX13 Seattle22:24 28-Aug-26

BioNTech Terminates Phase 2 Trial Of Autogene Cevumeran In Colorectal Cancer RTT News16:37 28-Aug-26

BioNTech Stock Dips After BNT122-01 Trial Termination Benzinga16:19 28-Aug-26

FDA approves updated COVID vaccines for 2026-27 season Just The News16:12 28-Aug-26

FDA Approves Updated Covid Vaccines NewsMax13:10 28-Aug-26

FDA approves latest version of Pfizer's Covid-19 mRNA vaccine UPI00:30 28-Aug-26

Pfizer and BioNTech Receive U.S. FDA Approval for Xfg-adapted Covid-19 Vaccine Business Wire (Press Release)21:30 27-Aug-26

BreakBio, the Third Player in Personalized Drugs, Enters the Clinic PR Newswire (Press Release)22:44 24-Aug-26

BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger… Barchart15:20 24-Aug-26

BioNTech (BNTX) Is Up 27.3% After Novel Pumitamig Combo Data in Lung Cancer – Has The Bull Case Changed? Simply Wall St14:26 24-Aug-26

Moderna Stock Cools Off After-Hours, Following Massive 177% Cancer Vaccine Rally — Merck, Pfizer and BioNTech Among… Benzinga04:40 20-Aug-26

Why Is BioNTech Stock Surging on Wednesday? Benzinga17:43 19-Aug-26

U.S. Listings For German Scale-ups | Part 2 JD Supra18:06 18-Aug-26

view more headlines

14 Sept 15:41

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.